Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bristow

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2017
4-1BB Agonist Focuses CD8<sup>+</sup> Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic CancerDonastas Sakellariou-Thompson, Marie-Andrée Forget, Caitlin Creasy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2026
Reprogramming of Cellular Plasticity via ETS and MYC Core-regulatory Circuits During Response to MAPK Inhibition in BRAF-mutant Colorectal CancerHey Min Lee, Zhao Zheng, Alexey Sorokin, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Combined KRAS<sup>G12C</sup> and SOS1 inhibition enhances and extends the anti-tumor response in KRAS<sup>G12C</sup>-driven cancers by addressing intrinsic and acquired resistanceVenu Thatikonda, Hengyu Lu, Sabine Jurado, et al.
Biorxiv : the Preprint Server for Biology|July 4, 2025
Reprogramming of Cellular Plasticity via ETS and MYC Core-regulatory Circuits During Response to MAPK Inhibition in BRAF-mutant Colorectal CancerHey Min Lee, Zhao Zheng, Alexey Sorokin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2017
PAF promotes stemness and radioresistance of glioma stem cellsDerrick Sek Tong Ong, Baoli Hu, Yan Wing Ho, et al.
Cancer Research|September 14, 2021
Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast CancerKurt W Evans, Erkan Yuca, Stephen S Scott, et al.
JCO Clinical Cancer Informatics|August 9, 2022
Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non-Small-Cell Lung Cancer Data SetStephanie T Schmidt, Neal Akhave, Ryan E Knightly, et al.
Gastroenterology|March 22, 2021
Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal CancerAkira Inoue, Frederick S Robinson, Rosalba Minelli, et al.
Nature Cancer|August 5, 2024
Co-targeting SOS1 enhances the antitumor effects of KRAS<sup>G12C</sup> inhibitors by addressing intrinsic and acquired resistanceVenu Thatikonda, Hengyu Lyu, Sabine Jurado, et al.
Science Advances|February 9, 2022
A functional genomic approach to actionable gene fusions for precision oncologyJun Li, Hengyu Lu, Patrick Kwok-Shing Ng, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2017
4-1BB Agonist Focuses CD8<sup>+</sup> Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic CancerDonastas Sakellariou-Thompson, Marie-Andrée Forget, Caitlin Creasy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2026
Reprogramming of Cellular Plasticity via ETS and MYC Core-regulatory Circuits During Response to MAPK Inhibition in BRAF-mutant Colorectal CancerHey Min Lee, Zhao Zheng, Alexey Sorokin, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Combined KRAS<sup>G12C</sup> and SOS1 inhibition enhances and extends the anti-tumor response in KRAS<sup>G12C</sup>-driven cancers by addressing intrinsic and acquired resistanceVenu Thatikonda, Hengyu Lu, Sabine Jurado, et al.
Biorxiv : the Preprint Server for Biology|July 4, 2025
Reprogramming of Cellular Plasticity via ETS and MYC Core-regulatory Circuits During Response to MAPK Inhibition in BRAF-mutant Colorectal CancerHey Min Lee, Zhao Zheng, Alexey Sorokin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2017
PAF promotes stemness and radioresistance of glioma stem cellsDerrick Sek Tong Ong, Baoli Hu, Yan Wing Ho, et al.
Cancer Research|September 14, 2021
Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast CancerKurt W Evans, Erkan Yuca, Stephen S Scott, et al.
JCO Clinical Cancer Informatics|August 9, 2022
Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non-Small-Cell Lung Cancer Data SetStephanie T Schmidt, Neal Akhave, Ryan E Knightly, et al.
Gastroenterology|March 22, 2021
Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal CancerAkira Inoue, Frederick S Robinson, Rosalba Minelli, et al.
Nature Cancer|August 5, 2024
Co-targeting SOS1 enhances the antitumor effects of KRAS<sup>G12C</sup> inhibitors by addressing intrinsic and acquired resistanceVenu Thatikonda, Hengyu Lyu, Sabine Jurado, et al.
Science Advances|February 9, 2022
A functional genomic approach to actionable gene fusions for precision oncologyJun Li, Hengyu Lu, Patrick Kwok-Shing Ng, et al.
Pageof 12